Home › Funds › Vanguard Group › ALGS
Vanguard Group position in ALGS
ALIGOS THERAPEUTICS INC · Health Care
Latest position (Q4 2025)200.40K sh
Reported value held$1.87M
Portfolio Weight0.00%
First reportedQ1 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2021 | 614.76K | $13.98M | New |
| Q2 2021 | 983.30K | $20.05M | Add |
| Q3 2021 | 1.28M | $19.78M | Add |
| Q4 2021 | 1.37M | $16.32M | Add |
| Q1 2022 | 1.28M | $2.76M | Reduce |
| Q2 2022 | 1.06M | $1.29M | Reduce |
| Q3 2022 | 1.09M | $1.20M | Add |
| Q4 2022 | 1.01M | $965.76K | Reduce |
| Q1 2023 | 1.02M | $888.58K | Hold |
| Q2 2023 | 994.71K | $965.87K | Reduce |
| Q3 2023 | 1.01M | $754.93K | Add |
| Q4 2023 | 1.01M | $671.74K | Hold |
| Q1 2024 | 1.01M | $992.81K | Hold |
| Q2 2024 | 1.60M | $558.38K | Add |
| Q3 2024 | 63.81K | $552.63K | Reduce |
| Q4 2024 | 96.76K | $3.85M | Add |
| Q1 2025 | 140.75K | $1.16M | Add |
| Q2 2025 | 139.78K | $1.01M | Reduce |
| Q3 2025 | 171.69K | $1.68M | Add |
| Q4 2025 | 200.40K | $1.87M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ALGS
- Marshall Wace 246.58K sh · $1.42M · Q2 2026
- Hillhouse Capital (HHLR Advisors) 76.25K sh · $439.94K · Q2 2026
- D. E. Shaw & Co 66.46K sh · $383.49K · Q2 2026
- UBS Group AG 59.99K sh · $346.12K · Q2 2026
- Geode Capital Management 47.17K sh · $272.32K · Q2 2026
- BlackRock Inc 30.29K sh · $174.78K · Q2 2026
- Renaissance Technologies 10.80K sh · $62.32K · Q2 2026
- Citigroup Inc 1.81K sh · $10.43K · Q2 2026
- JPMorgan Chase & Co 344 sh · $1.87K · Q2 2026
- Morgan Stanley 204 sh · $1.18K · Q2 2026
- Wells Fargo & Co 100 sh · $577 · Q2 2026